Mutations that increase expression of the EmrAB-TolC efflux pump confer increased resistance to nitroxoline in Escherichia coli.

Saved in:
Bibliographic Details
Title: Mutations that increase expression of the EmrAB-TolC efflux pump confer increased resistance to nitroxoline in Escherichia coli.
Authors: Puértolas-Balint F; Department of Medical Biochemistry and Microbiology, Uppsala University, SE-75123, Uppsala, Sweden., Warsi O; Department of Medical Biochemistry and Microbiology, Uppsala University, SE-75123, Uppsala, Sweden., Linkevicius M; Department of Medical Biochemistry and Microbiology, Uppsala University, SE-75123, Uppsala, Sweden.; Department of Public Health Solutions, National Institute for Health and Welfare (THL), Helsinki, Finland., Tang PC; Department of Medical Biochemistry and Microbiology, Uppsala University, SE-75123, Uppsala, Sweden.; Department of Medical Cell Biology, Uppsala University, SE-75123, Uppsala, Sweden., Andersson DI; Department of Medical Biochemistry and Microbiology, Uppsala University, SE-75123, Uppsala, Sweden.
Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2020 Feb 01; Vol. 75 (2), pp. 300-308.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1460-2091
DOI:10.1093/jac/dkz434